CMP Pharma’s portfolio of FDA-approved ready-made oral liquid products: Tadliq® (Tadalafil) Oral Suspension, 20 mg/5mL, the first and only FDA-approved liquid oral suspension of Tadalafil; Norliqva® (Amlodipine) Oral Solution, 1mg/mL, the first FDA-approved liquid solution for hypertension in adults and children 6 years and older; and CaroSpir® (Spironolactone) Oral Suspension, 25 mg/5mL the first and only FDA-approved oral suspension of the potassium-sparing diuretic spironolactone.